COLUMBIA, Md. - Xcision Medical Systems, LLC, a medical technology company that develops advanced stereotactic radiotherapy solutions to improve cancer care, will demonstrate GammaPod at The European Society for Radiotherapy and Oncology (ESTRO) on May 3-7 in Glasgow,...
Press Releases & Articles
Minimizing Treatment Fractions for Early-Stage Breast Cancer Patients
April 24, 2024 | Xcision Article Missed Xcision’s webinar on how to reduce radiation toxicity by reducing the treatment to a single fraction? In this clinical education webcast, Dr. Marco Trovò from Azienda sanitaria universitaria Friuli Centrale (ASU FC) in Udine,...
No Pain, No Anesthesia, No Scars: The Driving Idea to Develop GammaPod
Cedric Yu, GammaPod inventor and founder of Xcision Medical Systems, LLC, talks about how an idea to create a more convenient radiotherapy technology came about—and how the GammaPod is now available to women with breast cancer. The idea of a better radiation treatment...
Xcision to feature GammaPod™ at Arab Health 2024
COLUMBIA, Md., January 27, 2024 Xcision to feature GammaPod™ at Arab Health 2024 GammaPod provides new treatment options for breast cancer patients Xcision Medical Systems, LLC, a medical technology company developing advanced stereotactic radiotherapy solutions to...
New proposed rule continues cuts to Medicare reimbursement; Legislative remedies needed to protect patients’ access to care
Medicare spends less on all radiation therapy services than it does on just three top cancer drugs, although radiation is utilized by twice as many beneficiaries. Despite this outsized value, CMS has cut radiation oncology physician fee schedule payments by over 20%...
World’s Largest Medtech Accelerator Announces 61 Startups for its 2023 Cohort
“The 2023 MedTech Innovator Cohort once again includes passionate medtech entrepreneurs from around the globe. We look forward to working with our corporate partners and industry advisors over the course of the program, to help these startups advance their medical...
Hundred treatments carried out and completed with GammaPod in Udine, Italy
It’s been one year since the press conference which set off the clinical use of GammaPod in Udine. A year of intense work for the staff of the ASUFC Radiotherapy department, which led to the successful completion of the hundredth stereotactic radiotherapy breast...
ASTRO emphasizes support for value-based care as CMS final rule confirms indefinite delay to RO Model
“The Centers for Medicare and Medicaid Services (CMS) today finalized an indefinite delay for the Radiation Oncology Model. ASTRO continues to believe that episodic payments will improve access and quality, advance health equity and reduce costs in cancer care. We...
Xcision Announces Start of Breast Cancer Treatments Using GammaPod™ Stereotactic Radiotherapy System at Leading Italian Hospital
COLUMBIA, Md. (PRWEB) April 12, 2022 Xcision Medical Systems, LLC today announced that Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) in Italy recently began treating patients with the GammaPod™ Stereotactic Radiotherapy System, a breast cancer treatment...
CMS Unveils Mandatory Participants for Radiation Oncology Alternative Payment Model (RO-APM) – NEWS ALERT
24 September 2020 The Centers for Medicare and Medicaid Services (CMS) has announced the finalized rule for the Radiation Oncology Alternative Payment Model (RO-APM), which is scheduled to be implemented on January 1, 2021. According the CMS, the model is intended...